Form 4: LeMaitre Vascular CEO Awarded Stock Options and Restricted Stock Units

Sentiment:

Executive Compensation Disclosure


LeMaitre Vascular's CEO, George W. LeMaitre, received stock options and restricted stock units as part of his compensation package.

Summary

  • LeMaitre Vascular's CEO, George W. LeMaitre, was granted stock options to purchase 4,945 shares at $101.12 per share.
  • He also received 28,377 restricted stock units.
  • The stock options vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the following three years.
  • The restricted stock units also vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the following three years.
  • The restricted stock unit award includes a provision for the company to withhold shares to cover taxes due on each vesting date.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally positive for aligning management interests with shareholders. There are no negative surprises or concerns.

Positives

  • The stock options and restricted stock units serve as an incentive for the CEO to drive long-term value for the company.
  • The vesting schedule encourages the CEO's continued commitment to the company over the next four years.

Risks

  • The value of the stock options is dependent on the future performance of the company's stock price.
  • The vesting of the restricted stock units could result in dilution of existing shareholders' equity.

Industry Context

The granting of stock options and restricted stock units is a common practice in the corporate world to incentivize and retain key executives.

Comparison to Industry Standards

  • Stock option and restricted stock unit grants are standard practice for executive compensation across various industries, including medical device companies.
  • Vesting schedules of four years are also common, aligning executive interests with long-term company performance.
  • Companies like Medtronic and Stryker also use similar compensation methods to attract and retain top talent.

Stakeholder Impact

  • Shareholders may view the stock options and restricted stock units as a positive incentive for the CEO to increase shareholder value.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
2024-12-06Grant date for stock options and restricted stock units.
2024-12-10Date of signature by John Pitfield.
2031-12-06End of the vesting period for the restricted stock units.

Keywords

stock options, restricted stock units, executive compensation, vesting, LeMaitre Vascular, LMAT, George W. LeMaitre

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.